PlainRecalls
FDA Drug Moderate Class II Terminated

Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15

Reported: October 26, 2016 Initiated: July 12, 2016 #D-0112-2017

Product Description

Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15

Reason for Recall

Superpotent Drug: Failure of assay specifications in the capsule.

Details

Units Affected
17,128 (30-count blister packs)
Distribution
Nationwide
Location
Rockville, MD

Frequently Asked Questions

What product was recalled?
Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15. Recalled by Supernus Pharmaceuticals, Inc.. Units affected: 17,128 (30-count blister packs).
Why was this product recalled?
Superpotent Drug: Failure of assay specifications in the capsule.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 26, 2016. Severity: Moderate. Recall number: D-0112-2017.